tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Gerberry, 247 are a BUY (68.23%), 31 are a SELL (8.56%), 84 are a HOLD (23.2%).
Analyst Jason Gerberry, currently employed at BAML, carries an average stock price target met ratio of 64.45% that have a potential upside of 32.95% achieved within 314 days.
Jason Gerberry’s has documented 735 price targets and ratings displayed on 66 stocks. The coverage is on Healthcare, Industrials, Energy sectors.
Most recent stock forecast was given on PCVX, Vaxcyte.
Analyst best performing recommendations are on PROK (PROKIDNEY CORP.).
The best stock recommendation documented was for PROK (PROKIDNEY CORP.) at 6/30/2025. The price target of $1 was fulfilled within 8 days with a profit of $0.41 (69.49%) receiving and performance score of 86.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$50.66 (19.16%)
$265
22 days ago
(10-Sep-2026)
6/7 (85.71%)
$60 (23.53%)
115
Buy Since 12-Sep-2025
$303
$38.66 (14.63%)
$298
1 months 12 days ago
(20-Aug-2026)
2/12 (16.67%)
$41.17 (15.72%)
35
Buy Since 09-Dec-2021
$300
$35.66 (13.49%)
$295
1 months 15 days ago
(17-Aug-2026)
14/16 (87.5%)
$49.67 (19.84%)
506
Hold Since 13-Aug-2026
$300
$35.66 (13.49%)
1 months 19 days ago
(13-Aug-2026)
1/2 (50%)
$49.18 (19.61%)
115
Buy Since 23-Jan-2023
$260
$-4.34 (-1.64%)
$235
1 months 22 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
133
Which stock is Jason Gerberry most bullish on?
Which stock is Jason Gerberry most reserved on?
What Year was the first public recommendation made by Jason Gerberry?
